ANN ARBOR, Mich., – April 27, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and

Company is in its strongest financial position ever, having raised $8 million in 16 months ANN ARBOR, Mich., – April 14, 2022– Kraig Biocraft Laboratories,

ANN ARBOR, Mich., – March 7, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and

ANN ARBOR, Mich., – February 16, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and

ANN ARBOR, Mich., – February 10, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and

Kraig Biocraft Laboratories Readies for First Commercial Shipment of Recombinant Spider Silk and Accelerated Growth in Production